Unow™ Troponin I Fluorescence Immunoassay

Fluorescence immunoassay POCT rapid diagnostic kits for point-of-care testing, enabling quick detection of biomarkers at the bedside or clinical setting. These kits utilize fluorescence technology to deliver sensitive and specific results without requiring centralized laboratory infrastructure, supporting rapid clinical decision-making.

Point-of-care rapid immunoassay for cardiac biomarker detection. Supports rapid assessment of cardiac events and myocardial injury in clinical settings.

Cardiac Injury Triple Test Kit using fluorescence immunoassay technology for rapid detection of cardiac biomarkers. Enables simultaneous measurement of multiple cardiac injury markers to support acute coronary syndrome diagnosis and risk stratification in clinical laboratory and point-of-care settings.

Point-of-care rapid immunoassay for infectious disease detection. Enables fast identification of pathogens and infectious agents in clinical environments.

Portable fluorescence immunoassay system for rapid point-of-care diagnostic testing. Enables detection and quantification of biomarkers in clinical specimens through fluorescence-based immunoassay methodology. Designed for laboratory and clinical use with portable form factor for decentralized testing applications.

Rapid immunoassay kits designed for point-of-care testing in clinical settings. Provide quick turnaround results for various medical conditions with high accuracy.

A fluorescence immunoassay test that uses fluorescence technology to measure compounds including drugs, hormones, and proteins, offering a simple, rapid, and sensitive technique for in vitro diagnostics.

A microfluidic-based fluorescence immunoassay kit designed for point-of-care testing (POCT) applications. The kit leverages microfluidic chip technology for biological detection and analysis. It is part of Novos Biotech's product line for molecular diagnostics and has been selected for innovative medical device demonstration projects.

Rapid immunoassay test for quantitative detection of cardiac troponin I (cTnI) in serum or plasma. Used for acute myocardial infarction diagnosis and cardiac risk stratification in emergency and clinical laboratory settings. Delivers results within minutes, enabling fast clinical decision-making for chest pain patients.

Sensitive immunoassay tests for cardiac troponin detection in acute myocardial infarction diagnosis. These products enable rapid assessment of myocardial damage in emergency settings.

High-sensitivity immunoassay for cardiac troponin I measurement in serum and plasma. Critical for acute myocardial infarction diagnosis and risk assessment.